Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06214507 · ClinicalTrials.gov registry record
Danon Disease Natural History Study
A clinical trial of Danon Disease, sponsored by Rocket Pharmaceuticals.
- Recruiting
- Registry status
- 60
- Enrollment target
- 13
- Study locations
NCT06214507: Recruiting study of Danon Disease, sponsored by Rocket Pharmaceuticals.
NCT06214507 is a study of Danon Disease that is actively recruiting participants, run by Rocket Pharmaceuticals. The registered enrollment target is 60 participants. The trial reports 13 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06214507, a study of Danon Disease, is actively recruiting participants, sponsored by Rocket Pharmaceuticals.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 13
- Study locations
Study Summary
The goal of this international observational study is to learn about the natural history of Danon disease in male patients (≥8 years of age) and female patients (8 to 50 years of age).
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (13)
Other
- German Heart Center Munich - München
- Sheba Medical Center - Ramat Gan
- Azienda Ospedaliero Universitaria - Florence
- University College London - Great Ormond Street Institute of Child Health - London
Arizona
- Phoenix Children's Hospital - Phoenix
California
- University of California, San Diego - La Jolla
Colorado
- Children's Hospital Colorado - Aurora
Florida
- University of Florida College of Medicine - Gainesville
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University - St Louis
New York
- Columbia University Medical Center/New York Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2030-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06214507
The ClinicalTrials.gov registry entry for NCT06214507 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rocket Pharmaceuticals, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Danon Disease appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT06214507 reports 13 study locations spanning 10 distinct geographic areas - top geographies include Other, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT06214507 about?
NCT06214507 is a clinical study titled "Danon Disease Natural History Study". The goal of this international observational study is to learn about the natural history of Danon disease in male patients (≥8 years of age) and female patients (8 to 50 years of age).
What is the current status of trial NCT06214507?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2023-12-20. Estimated completion is 2030-03.
What conditions does trial NCT06214507 study?
This clinical trial studies the following conditions: Danon Disease.
What interventions are being tested in trial NCT06214507?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06214507?
This trial is sponsored by Rocket Pharmaceuticals, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06214507 being conducted?
This trial has 13 study locations across Arizona, California, Colorado, Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Danon Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.